CPRX FY 2011 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$6M

Net Income

-$6M

EPS (Diluted)

$-0.29

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$416,735

Balance Sheet

Total Assets

$6M

Total Liabilities

$2M

Stockholders' Equity

$4M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$488,958	-100.0%
Gross Profit	$0	$488,958	-100.0%
Operating Income	-$6M	-$4M	-51.1%
Net Income	-$6M	-$4M	-59.5%